Bright Minds Biosciences Current Ratio Growth & History (DRUG)

Bright Minds Biosciences's current ratio was 36.10 for fiscal 2025.

View full Bright Minds Biosciences company overview

Bright Minds Biosciences annual current ratio history

Bright Minds Biosciences annual current ratio

Fiscal yearPeriod endedCurrent ratioChangeGrowth
20252025-09-3036.1024.78+218.80%
20242024-09-3011.32−12.93−53.32%
20232023-09-3024.2616.14+198.94%
20222022-09-308.11−23.27−74.14%
20212021-09-3031.38

Bright Minds Biosciences current ratio trends

Between the periods ended 2021-09-30 and 2025-09-30, Bright Minds Biosciences's current ratio increased from 31.38 to 36.10, a change of 4.72. The latest reported quarter, Q3 2026, shows 121.97.

About the metric

What the current ratio means

The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.

Calculation and source

How the current ratio is calculated

TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Bright Minds Biosciences source filings ↗

Community posts

It’s quiet here.

No posts about DRUG yet. Start the conversation.

Write the first post